Series A funding round for Enlaza Therapeutics raising $100M in April 2024
Series A funding round for Enlaza Therapeutics raising $100M in April 2024
| Investor | Firm Type | Partner |
|---|
J.P. 摩根LEAD | Private | — |
| Venture Capital | — | |
| Corporate Venture Capital | — | |
| Venture Capital | — | |
| Private | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$161M
Top Valuation
-
Enlaza Therapeutics raised $100M in a Series A round.
The round was announced on 04/01/24.
The round was led by Stephen Squinto.